Daewoong Pharma대웅제약

Daewoong Pharma069620· Biotech & PharmaInitiation

Daewoong Pharma: Profits Recovered Since 2024 While the Share Price Fell Roughly 22% Over One Year

Daewoong Pharma's trailing revenue was ₩1.6T with an operating margin of 11.7% as of H1 2026, while the shares closed at ₩103,600, near the 52-week low of ₩102,200. Trailing P/E is 6.1 and P/B is 1.1, but free cash flow is negative and several data points are not available.

Oct 13, 20260 views